Systematic Review: Efficacy and Safety of Rituximab for Adults with Idiopathic Thrombocytopenic Purpura-Reference-Cited by-同舟云学术

Systematic Review: Efficacy and Safety of Rituximab for Adults with Idiopathic Thrombocytopenic Purpura

Published:2007-01-02 Issue:1 Volume:146 Page:25
ISSN:0003-4819
Container-title:Annals of Internal Medicine
language:en
Short-container-title:Ann Intern Med

Author:

Arnold Donald M.¹,Dentali Francesco¹,Crowther Mark A.¹,Meyer Ralph M.¹,Cook Richard J.¹,Sigouin Christopher¹,Fraser Graeme A.¹,Lim Wendy¹,Kelton John G.¹

Affiliation:

1. From McMaster University and Juravinski Cancer Centre, Hamilton, Ontario, Canada; Insubria University, Varese, Italy; National Cancer Institute of Canada Clinical Trials Group, Kingston, Ontario, Canada; Queen’s University, Kingston, Ontario, Canada; University of Waterloo, Waterloo, Ontario, Canada.

Publisher

American College of Physicians

Subject

General Medicine,Internal Medicine

Cited by 448 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Risk of Severe Infections Secondary to the Use of Targeted Therapies in Hematological Malignancies;Cureus;2024-01-10

2. The many facets of immune-mediated thrombocytopenia: Principles of immunobiology and immunotherapy;Blood Reviews;2024-01

3. Early immunomodulation in immune thrombocytopenia—A report of the ICIS meeting in Lenzerheide, Switzerland 2022;British Journal of Haematology;2023-09-21

4. Successful treatment with belimumab for immune thrombocytopenia associated with systemic lupus erythematosus: A report of two cases;Modern Rheumatology Case Reports;2023-09-18

5. Primary and secondary immune thrombocytopenia (ITP): Time for a rethink;Blood Reviews;2023-09